So a brief breakdown besides the parts where Jeff talks

New Post Public Reply Private Reply Replies (3) Message Board
Ortiz26
5,150
So a brief breakdown besides the parts where Jeff talks about his company and other topics besides OWC, just going through my handwritten notes:

13 minutes in spoke about Israel a lot throughout throughout the interview being the mecca cannabis capital of the world, government fully supportive. Recreational will eventually be big, but Pharma is where the money is at.
Says patients want to be able to walk into pharmacies and have access to products like the OWC creme. GW will have the first FDA approved drug in the USA. OWC is starting out the same way GW did, but despite them being a 3.2 billion market cap, still considers GW to be a small company.
21 minutes in talks about the patents but has little knowledge about them but confirms OWC has them. The IRB approval for the creme. OWC approach is significant, have the ability to get products in the US and throughout the world. Spoke about the two deals one in the Czech Republic and other in Maryland for manufacturing and distribution.
29 minutes in spoke highly about Dr. Baruch and his background. Then spoke about the two women they recently hired and how significant their backgrounds are moving forward.
32 minutes said "I do not consider OWC a penny stock"
OWC is a very professional company, if they have news to put out, they'll put it out. Look at all of the milestones and achievements the company has done, very impressive.
34 minutes in he spoke about the conference. He admitted that he may have spoken to long, then Ziv began to talk and sometimes gets very excited that people were having a hard time understanding him due to his accent. He said the company could've did a better job overall, but said the conference was still incredible.
Friedland is offering free seats to anyone that emails the potstock radio show to the San Jose event March 28th and March 29th. He will meet and greet personally and give you a copy of his book
38 minutes in he spoke about Alan B., who claimed there are only a handful of legit cannabis companies out there out of around 300, OWC being one of them. What company has $2 mill cash on hand? OWC does. How many companies have no debt? OWC does. Look at the 8k's, buy in his vision.
OWC has what GW doesn't have, the backing and support of the Israeli government.
50 minutes in he speaks about the creme and the state by state laws. He wants the creme to be available to anyone who walks into a dispensary that has psoriasis and the bud tender to offer the creme.
56 minutes in he speaks highly about the tablet and how effective it can become and how there is a huge marketplace for them. Then again goes into the conversation about OWC having $2 mill in the bank. Talks about the Multiple Myleoma testing and how successful the testing was killing 100% of the cells in 60% of the mice.
Friendland then adds he hopes OWC ramps up trials on Multiple Myleoma, fibromyalgia , and PTSD.
61 minutes in he talks about the message boards and how if you really want to learn and invest to do your own DD and read the 8k's, the website, etc. Stocks that are involved in real science. He said he owns shares in GW but not happy with what they are doing recently, called them an "Evil" company.
Also said things like certain companies like to put out news consistently, even if it's no news just to make headlines, that's not what OWC is and patience is the key. Real money is to be made on the pharma side.

Glad to have this guy on our side, he knows his stuff let's put it that way.

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

NextPlat Adjusts E-Commerce Goals Amid Trade Struggles

Updated Category News Views 129

Understanding NextPlat's Recent E-Commerce Adjustments NextPlat Corp (NASDAQ: NXPL), a global leader in e-commerce solutions, has announced critical changes to its operations as a response to the evolving trade landscape between the United States and China. The company anticipates that the recently imposed tariffs will significantly affect its ability to sell...

Continue Reading
Join the Exciting JiggAerobics Event for a Healthier You

Updated Category News Views 372

Join the Exciting JiggAerobics Event for a Healthier You Northeast Delta Human Services Authority (NEDHSA) is thrilled to announce its upcoming JiggAerobics event, now in its seventh installment. This lively gathering aims to promote health and fitness among people of all ages, offering a blend of fun and physical activity. Details of the Event The JiggAerobics event is...

Continue Reading
Key Insights from VanEck's Updated UK Prospectus for Investors

Updated Category News Views 172

VanEck UCITS ETFs plc: Comprehensive Prospectus Overview VanEck UCITS ETFs plc has recently issued a consolidated prospectus aimed at investors in the United Kingdom. This valuable document consolidates insights from earlier prospectus editions and offers a detailed guide into the company's shares. The consolidated prospectus serves as a transparent resource for...

Continue Reading
FirstFarms A/S Faces Challenges Amid FMD Outbreaks in Q1 Report

Updated Category News Views 148

FirstFarms A/S Reports Q1 Challenges Overview of FirstFarms' Financial Performance FirstFarms' financial results for the first quarter reveal unexpected challenges that have significantly influenced its operational landscape. The company faced notably low pig prices at the quarter's onset, accompanied by a disturbing outbreak of foot and mouth disease (FMD) affecting its...

Continue Reading
Shake Shack Reports Impressive Q4 Results Amid Expansion Plans

Updated Category News Views 236

Shake Shack's Fourth Quarter Performance Shake Shack, Inc. (NYSE: SHAK) has reported a remarkable fourth quarter, demonstrating resilience and notable growth in its financial performance. The company achieved an adjusted earnings per share of 26 cents, surpassing analysts’ expectations, which were set at 24 cents. Sales Growth and Financial Highlights During this...

Continue Reading